UGT2B17 and neoplasm: The mean UGT2B17 cytoplasmic expression is 6% (95% CI: 3–9) vs 19% (95% CI: 14–24) in the AR < 25% vs AR ≥ 25% tumours, respectively (P < 0.0019).